Five Features Of Value-Based Insurance Design Plans Were Associated With Higher Rates Of Medication Adherence

被引：39
作者：
Choudhry, Niteesh K. [1 ,2 ]
Fischer, Michael A. [1 ,2 ]
Smith, Benjamin F. [2 ]
Brill, Gregory [2 ]
Girdish, Charmaine [3 ]
Matlin, Olga S. [4 ]
Brennan, Troyen A. [5 ]
Avorn, Jerry [1 ,2 ]
Shrank, William H. [1 ,2 ]
机构：
[1] Harvard Univ, Sch Med, Boston, MA 02138 USA
[2] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
[3] CVS Caremark, Prospect Analyt, Woonsocket, RI USA
[4] CVS Caremark, Analyt Dev, Woonsocket, RI USA
[5] CVS Caremark, Woonsocket, RI USA
来源：
HEALTH AFFAIRS | 2014年 / 33卷 / 03期
关键词：
HEALTH; IMPACT; COPAYMENTS; SAVINGS;
D O I：
10.1377/hlthaff.2013.0060
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
Value-based insurance design (VBID) plans selectively lower cost sharing to increase medication adherence. Existing plans have been structured in a variety of ways, and these variations could influence the effectiveness of VBID plans. We evaluated seventy-six plans introduced by a large pharmacy benefit manager during 2007-10. We found that after we adjusted for the other features and baseline trends, VBID plans that were more generous, targeted high-risk patients, offered wellness programs, did not offer disease management programs, and made the benefit available only for medication ordered by mail had a significantly greater impact on adherence than plans without these features. The effects were as large as 4-5 percentage points. These findings can provide guidance for the structure of future VBID plans.
引用
收藏
页码：493 / 501
页数：9
相关论文
共 21 条
  • [1] Health System Factors and Antihypertensive Adherence in a Racially and Ethnically Diverse Cohort of New Users
    Adams, Alyce S.
    Uratsu, Connie
    Dyer, Wendy
    Magid, David
    O'Connor, Patrick
    Beck, Arne
    Butler, Melissa
    Ho, P. Michael
    Schmittdiel, Julie A.
    [J]. JAMA INTERNAL MEDICINE, 2013, 173 (01) : 54 - 61
  • [2] Impact of decreasing copayments on medication adherence within a disease management environment
    Chernew, Michael E.
    Shah, Mayur R.
    Wegh, Arnold
    Rosenberg, Stephen N.
    Juster, Iver A.
    Rosen, Allison B.
    Sokol, Michael C.
    Yu-Isenberg, Kristina
    Fendrick, A. Mark
    [J]. HEALTH AFFAIRS, 2008, 27 (01) : 103 - 112
  • [3] Evidence That Value-Based Insurance Can Be Effective
    Chernew, Michael E.
    Juster, Iver A.
    Shah, Mayur
    Wegh, Arnold
    Rosenberg, Stephen
    Rosen, Allison B.
    Sokol, Michael C.
    Yu-Isenberg, Kristina
    Fendrick, A. Mark
    [J]. HEALTH AFFAIRS, 2010, 29 (03) : 530 - 536
  • [4] The Impact of Reducing Cardiovascular Medication Copayments on Health Spending and Resource Utilization
    Choudhry, Niteesh K.
    Fischer, Michael A.
    Avorn, Jerry L.
    Lee, Joy L.
    Schneeweiss, Sebastian
    Solomon, Daniel H.
    Berman, Christine
    Jan, Saira
    Lii, Joyce
    Mahoney, John J.
    Shrank, William H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (18) : 1817 - 1824
  • [5] Full Coverage for Preventive Medications after Myocardial Infarction
    Choudhry, Niteesh K.
    Avorn, Jerry
    Glynn, Robert J.
    Antman, Elliott M.
    Schneeweiss, Sebastian
    Toscano, Michele
    Reisman, Lonny
    Fernandes, Joaquim
    Spettell, Claire
    Lee, Joy L.
    Levin, Raisa
    Brennan, Troyen
    Shrank, William H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (22) : 2088 - 2097
  • [6] Assessing The Evidence For Value-Based Insurance Design
    Choudhry, Niteesh K.
    Rosenthal, Meredith B.
    Milstein, Arnold
    [J]. HEALTH AFFAIRS, 2010, 29 (11) : 1988 - 1994
  • [7] Choudhry NK, 2009, AM J MANAG CARE, V15, P457
  • [8] Duru OK, 2010, AM J MANAG CARE, V16, P33
  • [9] Farley JF, 2012, AM J MANAG CARE, V18, P265
  • [10] Fendrick AM, 2001, AM J MANAG CARE, V7, P861
123